Results 261 to 270 of about 58,715 (292)
Some of the next articles are maybe not open access.
Medical Clinics of North America, 2008
Hepatic encephalopathy (HE) is a syndrome of neuropsychiatric dysfunction caused by portosystemic venous shunting, with or without intrinsic liver disease. Patients with hepatic encephalopathy often present with the onset of mental status changes ranging from subtle psychologic abnormalities to profound coma.
Juan, Córdoba, Beatriz, Mínguez
openaire +4 more sources
Hepatic encephalopathy (HE) is a syndrome of neuropsychiatric dysfunction caused by portosystemic venous shunting, with or without intrinsic liver disease. Patients with hepatic encephalopathy often present with the onset of mental status changes ranging from subtle psychologic abnormalities to profound coma.
Juan, Córdoba, Beatriz, Mínguez
openaire +4 more sources
Neurologic Clinics, 2002
Many patients with cirrhosis of the liver who appear to be overtly normal, using standard bedside examination techniques, test in the impaired range on one or more neuropsychological tests. These impairments affect the quality of life. Improvement in affected cognitive domains and the quality of life may follow the institution of treatment.
openaire +2 more sources
Many patients with cirrhosis of the liver who appear to be overtly normal, using standard bedside examination techniques, test in the impaired range on one or more neuropsychological tests. These impairments affect the quality of life. Improvement in affected cognitive domains and the quality of life may follow the institution of treatment.
openaire +2 more sources
Medical Clinics of North America, 1989
Hepatic encephalopathy (HE) is a complex reversible syndrome that can progress to coma. Recently, behavioral and electrophysiologic ameliorations of HE have been reported to occur in animal models of fulminant hepatic failure (FHF) and, in uncontrolled studies, in a majority of patients with FHF or cirrhosis following the intravenous administration of ...
S H, Gammal, E A, Jones
openaire +2 more sources
Hepatic encephalopathy (HE) is a complex reversible syndrome that can progress to coma. Recently, behavioral and electrophysiologic ameliorations of HE have been reported to occur in animal models of fulminant hepatic failure (FHF) and, in uncontrolled studies, in a majority of patients with FHF or cirrhosis following the intravenous administration of ...
S H, Gammal, E A, Jones
openaire +2 more sources
2011
Hepatic encephalopathy (HE) is a neuropsychiatric syndrome which can develop in the course of chronic and acute liver disease. It is characterized by cognitive and motoric deficits of varying severity. HE is functional in nature, potentially reversible and is thought to reflect the clinical manifestation of a low-grade cerebral edema, which exacerbates
openaire +4 more sources
Hepatic encephalopathy (HE) is a neuropsychiatric syndrome which can develop in the course of chronic and acute liver disease. It is characterized by cognitive and motoric deficits of varying severity. HE is functional in nature, potentially reversible and is thought to reflect the clinical manifestation of a low-grade cerebral edema, which exacerbates
openaire +4 more sources
Neurology, 1993
The approach to the management of patients with HE is summarized in Table 3. Other diagnoses need to be excluded and, after a diagnosis of HE is made on clinical and possibly electroencephalographic grounds, a search made for precipitants. Sedatives and opiates should be avoided, and steps taken to avoid hypoglycaemia, fluid overload or electrolyte ...
openaire +3 more sources
The approach to the management of patients with HE is summarized in Table 3. Other diagnoses need to be excluded and, after a diagnosis of HE is made on clinical and possibly electroencephalographic grounds, a search made for precipitants. Sedatives and opiates should be avoided, and steps taken to avoid hypoglycaemia, fluid overload or electrolyte ...
openaire +3 more sources
Minimal hepatic encephalopathy
Indian Journal of Gastroenterology, 2009Minimal hepatic encephalopathy (MHE) is the mildest form of spectrum of hepatic encephalopathy (HE). Patients with MHE have no recognizable clinical symptoms of HE but have mild cognitive and psychomotor deficits. The prevalence of MHE is high in patients with cirrhosis of liver and varies between 30% and 84%; it is higher in patients with poor liver ...
Radha K, Dhiman, Yogesh K, Chawla
openaire +2 more sources
Pharmacotherapy for Hepatic Encephalopathy
Drugs, 2010Hepatic encephalopathy (HE) is a challenging clinical complication of liver dysfunction with a wide spectrum of neuropsychiatric abnormalities that range from mild disturbances in cognitive function and consciousness to coma and death. The pathogenesis of HE in cirrhosis is complex and multifactorial, but a key role is thought to be played by ...
Paula V, Phongsamran +3 more
openaire +2 more sources
Inflammation and hepatic encephalopathy
Archives of Biochemistry and Biophysics, 2013Hepatic encephalopathy (HE) is a neuropsychiatric syndrome associated with both acute and chronic liver dysfunction, spanning a spectrum that ranges from mild neuropsychological disturbances to coma. The central role of ammonia in the pathogenesis of HE remains incontrovertible however, there is a robust evidence base indicating the important role of ...
Coltart, Iona +2 more
openaire +3 more sources
TIPS and Hepatic Encephalopathy
Seminars in Liver Disease, 1996The increasing use of TIPS in the treatment of complications of portal hypertension has to be reassessed, taking into account the substantial collective experience gained in many centers around the world. Specific indications need to be demonstrated using well-designed clinical trials, as it is now known that (contrary to the initial expectations), the
openaire +2 more sources
Pharmacoeconomics of Hepatic Encephalopathy
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2010Understanding and appreciating the science of pharmacoeconomics have become even more important for health care providers and insurers during the recent economic downturn. Evaluating the true costs of any disease is complex; both direct costs, such as costs of drug therapy and the provision of care, and indirect costs, such as lost earnings and reduced
openaire +2 more sources

